Aids Research Paper

Aids Research Paper-43
There are variations in the health community in recommendations on what treatment doctors should recommend for people with HIV.One question, for example, is determining when a doctor should recommend that a patient take antiretroviral drugs and what drugs a doctor may recommend.This field also includes the development of antiretroviral drugs.

There are variations in the health community in recommendations on what treatment doctors should recommend for people with HIV.

Tags: Antigone Conflict EssaysLife Essays ReligionSources Of Law EssayRandom Assignment In PsychologyEye Of The Beholder EssayHow To Start My Business PlanEnglish Language Coursework HelpMartin Luther And The Protestant Reion Essay

Wiley Online Library requires cookies for authentication and use of other site features; therefore, cookies must be enabled to browse the site.

Detailed information on how Wiley uses cookies can be found in our Privacy Policy.

A significant age acceleration effect could be detected in brain (7.4 years) and blood (5.2 years) tissue due to HIV-1 infection with the help of a biomarker of aging, which is known as epigenetic clock.

A long-term nonprogressor is a person who is infected with HIV, but whose body, for whatever reason, naturally controls the virus so that the infection does not progress to the AIDS stage.

Pre-exposure prophylaxis is sometimes an option for HIV-negative persons who feel that they are at increased risk of HIV infection, such as an HIV-negative person in a serodiscordant relationship with an HIV-positive partner.

Current research in these agents include drug development, efficacy testing, and practice recommendations for using drugs for HIV prevention.Despite enormous international collaborative efforts and detailed research into neutralizing antibodies and HIV specific cellular immunity, effective immunotherapy or an efficacious vaccine are not yet available.Major aspects of HIV infection are still not well understood, and much remains to be done to ensure affected people and communities benefit from the knowledge that has accumulated and that drives clinical and public health innovation."Pre-exposure prophylaxis" refers to the practice of taking some drugs before being exposed to HIV infection, and having a decreased chance of contracting HIV as a result of taking that drug.Post-exposure prophylaxis refers to taking some drugs quickly after being exposed to HIV, while the virus is in a person's body but before the virus has established itself.In both cases, the drugs would be the same as those used to treat persons with HIV, and the intent of taking the drugs would be to eradicate the virus before the person becomes irreversibly infected.Post-exposure prophylaxis is recommended in anticipated cases of HIV exposure, such as if a nurse somehow has blood-to-blood contact with a patient in the course of work, or if someone without HIV requests the drugs immediately after having unprotected sex with a person who might have HIV.As an innovative collaboration and cross-fertilization between Frontiers in Immunology and Frontiers in Public Health, HIV and AIDS aims to bring together studies on pathogenesis and on public health aspects.Three decades of HIV/AIDS research have brought understanding of and insight into all aspects of the immune pathology, anti-viral immunity, and the diverse manifestations of this disease.The binding causes conformation changes and results in the membrane fusion between HIV and cell membrane.Active infection occurs in most cells, while latent infection occurs in much fewer cells 1, 2 and at very early stages of HIV infection.


Comments Aids Research Paper